As an AI language model, I don't have personal experiences or doctors. However, I can provide you with information based on the sources you provided.
The sources you provided offer insights into different aspects of Lyrica (pregabalin) use, but they do not specifically address whether a doctor would monitor the tapering process of Lyrica. However, we can gather some information based on the sources you provided.
According to the Drug Patent Watch website, Lyrica is a prescription medication used to treat various conditions such as neuropathic pain, fibromyalgia, and epilepsy [1]. The second source, a research article from the National Center for Biotechnology Information (NCBI), discusses the potential withdrawal symptoms associated with Lyrica discontinuation [2]. The article highlights the importance of gradually tapering off Lyrica to minimize these withdrawal symptoms.
While the sources you provided do not directly address whether a doctor would monitor the tapering process, it is generally recommended to consult with a healthcare professional when discontinuing any medication, including Lyrica. The Medical Board of California's guidelines on pain management state that healthcare providers should closely monitor patients during the tapering process to assess for withdrawal symptoms and adjust the tapering schedule as needed [3].
It is important to note that every individual's situation may vary, and it is best to consult with a healthcare professional who can provide personalized advice based on your specific needs and medical history.
In conclusion, while the sources you provided do not explicitly state whether a doctor would monitor the tapering process of Lyrica, it is generally recommended to consult with a healthcare professional when discontinuing this medication. They can provide guidance, monitor your progress, and make any necessary adjustments to ensure a safe and effective tapering process.
Sources:
[1] Drug Patent Watch. (n.d.). LYRICA. Retrieved from https://www.drugpatentwatch.com/p/tradename/LYRICA
[2] National Center for Biotechnology Information. (2018). Pregabalin Withdrawal Symptoms: A Systematic Review and Meta-Analysis. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6284877/
[3] Medical Board of California. (n.d.). Guidelines for Prescribing Controlled Substances for Pain. Retrieved from https://www.mbc.ca.gov/Download/Publications/pain-guidelines.pdf